Abstract
Advances in the understanding of genetic engineering, protein expression, and Ig function have come together to allow for the rapid synthesis and production of a novel generation of potent immunomodulating reagents. Selective approaches that allow the isolation of desired specificities will be elucidated through meticulous engineering techniques. This, in turn, may eventually result in the fulfillment of the tremendous potential of engineered proteins for therapeutic and diagnostic applications.
| Original language | English |
|---|---|
| Pages (from-to) | 4031-4036 |
| Number of pages | 6 |
| Journal | Transplantation Proceedings |
| Volume | 30 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 1998 Dec 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Surgery
- Transplantation
Cite this
}
Immunoglobulin-cytokine fusion molecules : The new generation of immunomodulating agents. / Kim, Y. S.; Maslinski, W.; Zheng, X. X.; Schachter, A. D.; Strom, T. B.
In: Transplantation Proceedings, Vol. 30, No. 8, 01.12.1998, p. 4031-4036.Research output: Contribution to journal › Article
TY - JOUR
T1 - Immunoglobulin-cytokine fusion molecules
T2 - The new generation of immunomodulating agents
AU - Kim, Y. S.
AU - Maslinski, W.
AU - Zheng, X. X.
AU - Schachter, A. D.
AU - Strom, T. B.
PY - 1998/12/1
Y1 - 1998/12/1
N2 - Advances in the understanding of genetic engineering, protein expression, and Ig function have come together to allow for the rapid synthesis and production of a novel generation of potent immunomodulating reagents. Selective approaches that allow the isolation of desired specificities will be elucidated through meticulous engineering techniques. This, in turn, may eventually result in the fulfillment of the tremendous potential of engineered proteins for therapeutic and diagnostic applications.
AB - Advances in the understanding of genetic engineering, protein expression, and Ig function have come together to allow for the rapid synthesis and production of a novel generation of potent immunomodulating reagents. Selective approaches that allow the isolation of desired specificities will be elucidated through meticulous engineering techniques. This, in turn, may eventually result in the fulfillment of the tremendous potential of engineered proteins for therapeutic and diagnostic applications.
UR - http://www.scopus.com/inward/record.url?scp=0032438215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032438215&partnerID=8YFLogxK
U2 - 10.1016/S0041-1345(98)01330-X
DO - 10.1016/S0041-1345(98)01330-X
M3 - Article
C2 - 9865287
AN - SCOPUS:0032438215
VL - 30
SP - 4031
EP - 4036
JO - Transplantation Proceedings
JF - Transplantation Proceedings
SN - 0041-1345
IS - 8
ER -